Y J Biz (@yjbiz) 's Twitter Profile
Y J Biz

@yjbiz

Founder. I like ai, digital medtech, and a bit of geopol

ID: 1885751358516510721

calendar_today01-02-2025 18:06:08

59 Tweet

87 Followers

217 Following

Financial Times (@ft) 's Twitter Profile Photo

The spending required to build the data centres needed to power the AI era will be one of the biggest movements of capital in modern history. Who will pay for the $3tn AI building boom? We take a look here: on.ft.com/3V13KDi

The spending required to build the data centres needed to power the AI era will be one of the biggest movements of capital in modern history. 

Who will pay for the $3tn AI building boom? We take a look here: on.ft.com/3V13KDi
The Wall Street Journal (@wsj) 's Twitter Profile Photo

Volkswagen is pulling the plug on its retro electric bus in the U.S. next year, after the expiration of tax incentives for customers caused electric vehicle sales to tank. on.wsj.com/3Y4Q6Re

Mario Nawfal (@marionawfal) 's Twitter Profile Photo

🇪🇺🇺🇸 WHAT HAPPENED TO EUROPE'S TECH SCENE? THE NUMBERS ARE BRUTAL The U.S. is absolutely dominating the private unicorn game with 690 companies worth a combined $2.53 trillion. China has 162 unicorns totaling $702 billion, and the EU? Just 107 companies scraping together $333

🇪🇺🇺🇸 WHAT HAPPENED TO EUROPE'S TECH SCENE? THE NUMBERS ARE BRUTAL

The U.S. is absolutely dominating the private unicorn game with 690 companies worth a combined $2.53 trillion. 

China has 162 unicorns totaling $702 billion, and the EU? Just 107 companies scraping together $333
Dr Singularity (@dr_singularity) 's Twitter Profile Photo

An experimental drug "NU-9" halts Alzheimer's disease in animal model before symptoms begin Scientists at Northwestern University have tested an experimental drug called NU-9 in a mouse model of Alzheimer’s disease and found it dramatically reduces early brain changes linked to

An experimental drug "NU-9" halts Alzheimer's disease in animal model before symptoms begin

Scientists at Northwestern University have tested an experimental drug called NU-9 in a mouse model of Alzheimer’s disease and found it dramatically reduces early brain changes linked to
Barron's (@barronsonline) 's Twitter Profile Photo

Boston Dynamics announced the first commercial version of its Atlas humanoid robot, designed for industrial work, at CES in Las Vegas this week.